A novel apoptosis cascade mediated by lysosomal lactoferrin and its participation in hepatocyte apoptosis induced by d-galactosamine  by Katunuma, Nobuhiko et al.
FEBS Letters 580 (2006) 3699–3705A novel apoptosis cascade mediated by lysosomal lactoferrin and
its participation in hepatocyte apoptosis induced by D-galactosamine
Nobuhiko Katunumaa,*, Quang Trong Lea, Etsuko Murataa, Atsushi Matsuia, Eiji Majimab,
Naozumi Ishimaruc, Yoshio Hayashic, Atsushi Ohashia
a Institute for Health Sciences, Tokushima Bunri University, 180 Nishihamabouji, Yamashiro-cho, Tokushima 770-8514, Japan
b APRO Life Science Institute, 124-4 Itayashima, Myojin, Seto-cho, Naruto City, Tokushima 771-0360, Japan
c School of Dentistry, Tokushima University, 3-18-15 Kuramoto-cho, Tokushima 770-8504, Japan
Received 12 April 2006; revised 25 May 2006; accepted 26 May 2006
Available online 5 June 2006
Edited by Vladimir SkulachevAbstract A new apoptosis cascade mediated by lysosomal lac-
toferrin was found in apoptotic liver induced by D-galactosamine.
Caspase-3 and lactoferrin were increased in the apoptotic liver
cytoplasm and serum transaminases were elevated. Recombinant
lactoferrin stimulated procaspase-3 processing at 106–107 M
to an extent similar to that by granzyme B in vitro. Lactoferrin
changed procaspase-3 structure susceptible to the processing.
Synthetic peptide Y679-K695 in lactoferrin molecule inhibited
the processing of procaspase-3 by lactoferrin. Lactoferrin in
lysosomes was decreased and lactoferrin released into cytoplasm
was increased quantitatively in D-galactosamine induced apopto-
tic liver, and procaspase-3 in cytoplasm was processed to cas-
pase-3.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Many apoptosis cascades have been reported, and mito-
chondrial factor mediated apoptosis cascades have been well
established. Caspase-3 plays a central role in various apoptosis
cascades as an executive enzyme [1–4]. In 1998, we found that
an unknown protein extracted from lysosomes by digitonin en-
hanced procaspase-3 processing in liver cytoplasm [5,6]. After
that, we determined that the activating factor was lactoferrin
and suggested preliminary the existence of a new apoptosis
cascade mediated by lysosomal lactoferrin [7]. This paper re-
ports on the stimulation mechanisms of procaspase-3 process-
ing by lactoferrin at the enzymological aspects in detail and the
releasing mechanism of lysosomal lactoferrin into cytoplasm in
D-galactosamine-induced apoptotic hepatocyte. The patholog-
ical aspects of severe liver injury induced by D-galactosamine
have been well characterized by TUNEL staining and alsoAbbreviations: LPS, lipopolysaccharide; AFC, 7-amino-4-triﬂuorom-
ethyl-coumarin; ML, mitochondria-lysosome; AST, aspartate amino-
transferase; ALT, alanine aminotransferase; PAGE, polyacrylamide
gel electrophoresis; LRF, lactoferrin releasing factor
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that caspase-3 in the cytoplasm of apoptosis liver induced by
D-galactosamine was increased and the apoptosis was pro-
tected by epigallo-catechin gallate in green tea which inhibited
caspase-3 [11].
As the next step, we studied the molecular mechanism
underlying increases in the activity of activated caspase-3 in
the cytoplasm in vivo and found that a new procaspase-3 acti-
vating protein was released into the cytoplasm from lysosomes
in D-galactosamine induced apoptotic hepatocytes. We deter-
mined that this activating protein was a lactoferrin originally
located in lysosomes. Recombinant pure lactoferrin was found
to strongly stimulate procaspase-3 processing to form active
caspase-3 as same extent to that by granzyme B in vitro, and
the activation mechanisms were studied at the molecular level.
We reported that releasing mechanism of lysosomal lactoferrin
into the cytoplasm in D-galactosamine induced apoptotic rat
liver in vivo.
This paper reports on (1) stimulation mechanism of procas-
pase-3 processing by lactoferrin in vitro; (2) the mechanism by
which lysosomal lactoferrin is released into the cytoplasm after
D-galactosamine administration in vivo; (3) the existence of a
novel apoptosis cascade mediated by lysosomal lactoferrin.2. Materials and methods
2.1. Chemicals used
Caspase-3, procaspase-3, lipopolysaccharide (LPS), and lactoferrin
were all recombinant pure proteins purchased from Sigma Co.
(USA). The 17 residue peptide Y679-K695 (YEKYLGPQYVA-
GITNLK) of the lactoferrin molecule was chemically synthesized by
Asahi Techno-glass (Chiba, Japan) with 95% purity. Aspartylglutam-
ylvalinylaspartyl-7-amino-4-triﬂuoromethylcoumarin (DEVD-AFC)
was purchased from Peptide Institute Inc., Osaka, Japan.
2.2. Assay of procaspase-3 processing activity
Caspase-3 activity derived from procaspase-3 was determined from
the ﬂuorescence of AFC released from DEVD-AFC [5,11], and the en-
zyme activity was expressed in terms of AFC released in nmol/h/lg
protein or nmol/h [5,6,11]. The DEVD-AFC cleavage reaction cataly-
sed by caspase-3 and procaspase-3 processing reaction had the same
optimum pH. The rate of ﬂuorescent AFC production from the sub-
strate DEVD-AFC by active caspase-3 was much faster than the rate
of processing reaction of procaspase-3 at the optimum pH of 7.5.
AFC production could be expressed as the rate of procaspase-3 pro-
cessing, because procaspase-3 processing is the rate-determining step.
Negative staining of SDS–polyacrylamide gel electrophoresis (PAGE)blished by Elsevier B.V. All rights reserved.
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method of Fernandez et al. [12]. The processing activities were assayed
in the 78-kDa band eluents after removing SDS with renaturing buﬀer.
2.3. Detection of procaspase-3 activating protein using ﬂuorescent
reverse zymography
Our new double layer ﬂuorescent reverse zymographic method was
used for the detection of procaspase-3 activating proteins [21]. The
activator sample was applied to a 15% polyacrylamide gel copolymer-
ized with DEVD-AFC as the caspase-3 substrate, and the electropho-
resis was performed at 13 mA for 120 min. After removing SDS from
the gel with the renaturing buﬀer (2.5% Triton X-100), the gel was
incubated with 100 lM procaspase-3 solution at 37 C for 30 min.
The ﬂuorescent AFC band formed by caspase-3 was detected using a
UV-transilluminator [13].
2.4. Determination of amino acid sequence of the activating protein of
78-kDa
The intramolecular sequences of the activating protein isolated from
the Zn-negative staining SDS–PAGE was determined using an HP
G1005A protein sequencing system according to the Majima’s method
[14]. The protein in the 78-kDa band was digested with lysyl-endopep-
tidase and the peptide fragments were separated with reverse-phase
HPLC on a TSK gel ODS-120 T column (Tosoh) with a linear gradient
of acetonitrile in 0.05% triﬂuoroacetic acid. The amino acid sequences
of the main separated peptides were also determined using Majima’s
method [14].
2.5. Confocal immunohistochemical analysis of lactoferrin located in
liver lysosomes
Confocal immunoﬂuorescence analysis was performed on liver sec-
tions from C57BL/6 mice using FITC-labeled anti-lactoferrin pAb
(Cappel, Turnhout, Belgium) and PE-labeled anti-Lamp-1 mAb (Santa
Cruz Biotechnology Inc., Santa Cruz, CA).
2.6. Method of administration of D-galactosamine with LPS in vivo
Rat liver apoptosis was induced by D-galactosamine treatment using
Muntane’s method [8] by the intraperitoneal injection of D-galactos-
amine 0.5 g/kg or D-galactosamine 0.5 g/kg plus LPS 50 lg/kg. Twelve
hours after the injection, the rats were sacriﬁced to prepare the livers.
2.7. Preparation of lysosomes and cytoplasmic fraction of rat liver
The rat liver was gently homogenized with a Teﬂon pestle in 0.25 M
cold isotonic sucrose buﬀer. The suspension was centrifuged at
3500 · g for 10 min at 4 C to remove the nucleuses and cells. TheTable 1
Elevation of caspase-3 in liver cytoplasm and translocation of lysosomal lacto
D-galactosamine
Treatments Enzymes
In liver cytoplasm In liver
Caspase-3
(AFC
nM/mg/hr)
Activator,
78 kDa
(AFC nM/mg/h)
Activato
78 kDa
(AFC n
Normal 76.50 ± 9.42 25.0 ± 18.6 612.6 ±
d-GalN
ð300mg=kgÞ
ð500mg=kgÞ
ð700mg=kgÞ
8><
>:
1000.0 ± 360
180 ± 90.0 250.0 ±
322 ± 126.0 152.4 ±
609 ± 40 20.0 ±
LPS(50 lg/kg) 97.56 ± 21.65
D-GalN(500 mg)
+ LPS(50 lg/kg)
5159.73 ± 1250.37 1488.6 ± 576.9 *0
0.5 g/kg of the D-galactosamine plus 50 mg/kg of LPS was intraperitoneally i
The procaspase-3 activating activities (lactoferrin) translocated from the lysos
the method as follows. The quantitative amounts of the digitonin extracts of t
PAGE, and the procaspase-3 activating activities in the 78-kDa fractions and
the cytoplasms were assayed at the same time. Furthermore, these activa
lactoferrin protein amounts using ant lactoferrin antibody [18]. The activatin
extracts of cytoplasmic protein or lysosomal protein. The reciprocal mov
lysosomes and the cytoplasm were observed in D-galactosamine dose-dependsupernatant was centrifuged at 25000 · g for 20 min at 4 C to prepare
the lysosome-mitochondrial (ML) fraction, and then to prepare the
cytoplasm fraction, the supernatant was further centrifuged at
100000 · g for 60 min to remove the microsomes. To prepare pure
lysosomes, a two-phase partition centrifugation method in the presence
of 1 mM CaCl2 was used [15]. The lysosomal fractions for the assay of
procaspase-3 activation were extracted using a 40 lM digitonin solu-
tion with isotonic sucrose buﬀer.
2.8. Sample preparation for activity assay of the lysosomal procaspase-3
activating protein
The ML fractions of rat liver were extracted with 5 mL of digitonin
solution. After concentration to 1 mL, 30 lL portion of the extract was
applied to SDS gel to make SDS–PAGE. After removing the SDS, the
78-kDa fractions were eluted from the gel for determination of procas-
pase-3 activating activity or assay of the lactoferrin protein by the anti-
body. The activating activities were expressed as the AFC released nM/
h/mg protein (cytoplasmic protein, lysosomal protein or SDS–PAGE
band protein).
2.9. Statistical analysis
Values for expression are shown as means ± S.D. Quantitative diﬀer-
ences between values were statistically analyzed by Dunnett’s multiple
comparison t test P values <0.01 were considered to be signiﬁcant.3. Results and discussion
3.1. Detection of procaspase-3 activating protein in the
cytoplasm of D-galactosamine treated apoptotic liver cells
When D-galactosamine was administered intraperitoneally
to rats, caspase-3 activity in the liver cytoplasm was elevated
in a dose-dependent manner 12 h after injection and cotreat-
ment with LPS enhanced the apoptosis dramatically, as shown
in Table 1. The liver injury markers, aspartate aminotransfer-
ase (AST) and alanine aminotransferase (ALT), were strongly
elevated in the serum. Therefore, the increases of caspase-3
may participate in D-galactosamine induced liver injury [11].
In order to elucidate the mechanism of caspase-3 elevation
during the apoptosis, the activation factor of procaspase-3 in
the treated liver cytoplasm was determined by the following
procedure. Same amounts of cytoplasmic fraction and lyso-ferrin from lysosomes into cytoplasm in rat liver induced apoptosis by
lysosomes In serum
r,
M/mg/h)
Activator,
35 kDa
(AFC nM/mg/h)
AST (IU/l) ALT (IU/l)
210 100.0 23.37 ± 3.69 4.15 ± 1.17
150 95.0
247.37 ± 194.07 70.17 ± 51.1560 110.0
15 105.0
23.33 ± 6.25 6.67 ± 1.25
2154.31 ± 598.02 525.94 ± 140.74
njected to rats, and the 12 h after the injection, the rats were sacriﬁced.
omes into the cytoplasm in the apoptotic hepatocyte were assayed using
he lysosomes or the cytoplasm preparations were applied to make SDS–
those in the 35-kDa fractions from the lysosomes, and also those from
ting protein amounts in the cytoplasm corresponded to the released
g activities were expressed as the AFC released nM/h/mg protein in the
ements of the lactoferrin (procaspase-3 processing activities) in the
ently. Data are shown as the means ± S.D.: n = 3–5, *P < 0.01.
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Fig. 1. (a) Detection of procaspase-3 activating proteins in rat liver treated with D-galactosamine using double-layer ﬂuorescent reverse zymography.
The procaspase-3 activating proteins were detected using Katunuma’s double-layer ﬂuorescent reverse zymography; the method is described in the
text [13,21]. DEVD-AFC was used as a caspase-3 substrate. Lane 1: location of granzyme B as the procaspase-3 activating enzyme in the 32-kDa
band. Lane 2: Procaspase-3 activating protein in the 78-kDa band was detected in the liver cytoplasm fraction of D-galactosamine treated rats. Lane
3: Procaspase-3 activating proteins in the digitonin extracts of liver lysosome from normal rats in the 78-kDa band which corresponds to the band of
lactoferrin and the 35-kDa protein band which is unknown activating protein. (b) Procaspase-3 processing products by lactoferrin. SDS–PAGE gel
was stained by Coomassie blue. The products of procaspase-3 processing mediated by lactoferrin were the same as those produced by granzyme B.
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and electrophoresis was performed. After removing the
SDS from the PAGE with renaturing buﬀer, the procas-
pase-3 processing activities in the eluents were detected in
the 78-kDa fraction and the 35-kDa fraction using cas-
pase-3 formation from recombinant procaspase-3. The pro-
caspase-3 activating protein in the 78-kDa fraction was
increased in the cytoplasm and the activity in the lysosomes
was decreased in a reciprocal manner, as shown in Table 1.
Suﬃcient amounts of procaspase-3 were present in the nor-
mal cytoplasm, but active caspase-3 was not detected in the
normal cytoplasm. These data suggest that the procaspase-3
activating protein is originally located in the lysosomes un-
der normal conditions and that only the 78-kDa activating
protein was released into the cytoplasm by D-galactosamine
administration.
We then puriﬁed the 78-kDa activating protein from the li-
ver lysosomes to allow identiﬁcation. The partially puriﬁed
activating protein from the digitonin extracts of liver lyso-
somes was applied to SDS gels to separate the proteins. Two
kinds of activating proteins with molecular weights of 78-
kDa and 35-kDa were detected using ﬂuorescent reverse
zymography for processing protease detection [13,21], as
shown in Fig. 1(a) in lane 3. The 78-kDa band corresponds
to recombinant lactoferrin, and the 35-kDa band is an un-
known activating protein. The 35-kDa factor was not detected
in the cytoplasm of the apoptotic liver, therefore, the 35-kDa
factor does not participate in the apoptosis.3.2. Puriﬁcation and identiﬁcation of the 78-kDa lysosomal
activating protein as lactoferrin
A procaspase-3 activating protein was extracted with a
40 lM digitonin isotonic sucrose buﬀer from the puriﬁed lyso-
somes of bovine liver. The speciﬁc activity of the procaspase-3
processing enzyme in the digitonin extracts was 2.5 nmol AFC/
h/lg protein (formed from DEVD-AFC). The extracted pro-
tein was fractionated with 40–60% ammonium sulfate and then
heat treated at 70 C for 1 min. The supernatant was further
fractionated with 40–50% ethanol at 20 C. The fraction
was subsequently subjected to column chromatography using
Superdex G75, Mono Q and then Hydroxyapatite CHT5-I
BIO-RAD. The speciﬁc activity of the ﬁnal active fraction
was about 100 nmol AFC/h/lg protein. The purity was in-
creased about 40 times compared with that of the digitonin ex-
tracts. The puriﬁed sample had about the same activating
activity as that of the recombinant pure lactoferrin. The puri-
ﬁed fraction showed almost a single protein on the SDS–
PAGE.
The intramolecular amino acid sequence of the puriﬁed 78-
kDa activating protein eluted from the negative zinc staining
band in the SDS–PAGE was determined [12]. The sample
was hydrolyzed with lysyl-endopeptidase and the peptides pro-
duced were separated using reversed-phase HPLC. The amino
acid sequences of the two diﬀerent parts of the separated pep-
tides were determined. The amino acid sequences of these two
peptides were completely identical with those of the corre-
sponding parts of recombinant bovine lactoferrin. The amino
3702 N. Katunuma et al. / FEBS Letters 580 (2006) 3699–3705acid sequences of these two domains from the puriﬁed sample
were H435-P444 (n-H-S-S-L-D-C-V-L-R-P-c) and N653-E661 (n-
N-L-L-F-N-D-N-T-E-c). The molecular weight (78-kDa) and
the isoelectric point (5.4–5.7) of the puriﬁed activating protein
were the same as those of the recombinant bovine lactoferrin.
The processing product of procaspase-3 by the 78-kDa protein
was the same as that by recombinant lactoferrin as demon-
strated in Fig. 1(b). The same processing products of procas-
pase-3 by granzyme B were demonstrated.
3.3. Subcellular localization of lactoferrin in liver lysosomes
A two-phase Ficoll partition centrifugation method in 1 mM
CaCl2 was used to determine the subcellular localization of the
activating protein in rat liver [15]. The activating activity was
detected only in the lysosomal fraction, coinciding with the
location of cathepsin L, while the activity was not detected
in the swollen mitochondrial fraction, coinciding with glutamic
dehydrogenase (data not shown). The confocal immunohisto-
chemical staining of mouse liver, using a monoclonal anti-lac-
toferrin antibody and a PF-labeled anti-Lamp-1 antibody as
lysosomal markers, was used to determine the subcellular
localization of the lactoferrin (see Section 2). The lactoferrin
was detected only in the lysosomal particles located in the cell
membrane area, as Fig. 2 shows.Fig. 2. Subcellular localization of lactoferrin in rat liver using confocal
immunohistochemical staining. (a) Hematoxylin-eosin staining of
hepatocytes. (b) Lactoferrin localization in lysosomes using an anti-
lactoferrin antibody in green. (c) Lysosome staining by PF-labeled-
anti-Lamp-1 antibody in red. (d) Merged proﬁle of lactoferrin and
lysosomal marker Lamp-1. The lactoferrin was stained in the
lysosomes located in the cell membrane area.3.4. Activation mechanism of procaspase-3 by lactoferrin
The activation mode of the procaspase-3 processing reac-
tion mediated by pure lactoferrin was analyzed. Procas-
pase-3 was originally processed slowly via autocatalytic
reaction in Tris–HCl buﬀer at pH 7.5 and 37 C in vitro,
and 1 · 107 M lactoferrin strongly accelerated the autocata-
lytic processing to several-fold, as shown in Fig. 3(a). The
procaspase-3 processing rate mediated by 1 · 106 M lacto-
ferrin was about 7000–8000 nM AFC formed per hour, while
the autocatalytic rate was about 1000–1600 nM AFC formed
per hour. Speciﬁc activity of procaspase-3 processing reac-
tion catalyzed by lactoferrin was 432 nM AFC formed/h/
mg protein, while that by granzyme B was 515 nM AFC
formed/h/mg. Both catalytic activities showed about the
same level. The lactoferrin mediated procaspase-3 activating
reaction was not inhibited by various cysteine protease
inhibitors, including E-64 or serine protease inhibitors, and
anti-granzyme B antibody also did not inhibit the activation
reaction (data abbreviated). Since both apo-lactoferrin and
holo-lactoferrin had the same activation function and
1 · 107 M lactoferrin showed the enough activation
(Fig. 3(b)), the iron atom itself and the domains of the iron
atom binding did not participate in this activation reaction.
The processing products of recombinant procaspase-3 medi-
ated by lactoferrin were the same as those mediated by gran-
zyme B by Western blotting using the anti-caspase-3
antibody as shown in Fig. 1(b).
With regard to the activating mechanism of procaspase-3
processing by the lactoferrin, a lactoferrin–procaspase-3 com-
plex may be formed as an intermediate step. The lactoferrin
may play a chaperone-like role to alter the tertiary structure
of the procaspase-3 and render it more susceptible to being
processed. The binding aﬃnity for making the complex was
shown in Fig. 3(c), and the Km is about 1 · 1011 M. The lac-
toferrin did not have any eﬀect on the caspase-3 assay reaction.
The domain which participates in the binding of procaspase-3to the lactoferrin molecule was estimated to be Y679-K695 (YE-
KYLGPQYVAGITNLK) in lactoferrin. We reported previ-
ously that this domain was an inhibitory site of the
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Fig. 3. Activating mechanisms of procaspase-3 processing reaction mediated by lactoferrin. The procaspase-3 processing activity was assayed by the
formed caspase-3 activity and the formed caspase-3 activities from procaspase-3 are expressed as AFC formed nM/h in the vertical axis. Panel (a):
Reaction time course of procaspase-3 processing with lactoferrin. Panel (b): Dose-dependent activations of the procaspase-3 processing reaction
mediated by holo-lactoferrin or apo-lactoferrin. Apo-lactoferrin was prepared from holo-lactoferrin by the treatments at pH 2.0. The iron atoms
were released into the supernatant and no iron atoms were detected in the precipitated lactoferrin. Panel (c): Kinetical studies of the aﬃnity of
procaspase-3 for lactoferrin and the Km value.
N. Katunuma et al. / FEBS Letters 580 (2006) 3699–3705 3703lactoferrin for cysteine proteases [16]. This domain is highly
homologous with a common active site of the cystatin family.
The synthetic peptide Y679-K695 strongly inhibited not only theactivation reaction of the processing mediated by lactoferrin,
but also the autocatalytic processing reaction, as shown in
Fig. 4. This peptide may disturb the binding of procaspase-3
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rin may play an important role in the acceleration function by
participating in the binding of procaspase-3 to lactoferrin. To
explain the practical allosteric structural changes, the X-ray
co-crystallographic analysis of these complexes is required.
We previously reported a similar type of chaperone-like func-
tioning protein, a chondroitin-sulfate proteoglycan, which is a
potent enhancer of the autoprocessing of procathepsin L to
form the active mature cathepsin L [17]. We propose that these
kinds of speciﬁc accelerator proteins, or ‘‘enzymoids’’, may
participate in various post-translational processing reactions
in general.LRF
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Fig. 5. Schematic illustration of a new apoptosis cascade mediated by lysoso
D-galactosamine. Dotted blue line; a new apoptosis cascade mediated by lys3.5. A new apoptosis cascade mediated by lysosomal lactoferrin
To conﬁrm the translocation of the lactoferrin, the lactofer-
rin released in the cytoplasm was assayed quantitatively with
antibodies to lactoferrin using Sanchez’s method [18]. The lac-
toferrin released in the cytoplasm increased to 7 lg/mL of
cytoplasm upon treatment with 700 mg/kg D-galactosamine,
while no lactoferrin was detected in the normal liver cyto-
plasm. It is possible to consider that the lactoferrin located
in the lysosomes was released into the cytoplasm by D-galac-
tosamine administration dose-dependently in vivo as shown
in Table 1, although the releasing mechanisms are not known
at the present. The released procaspase-3 activating activity inReceptor
Death Signals 
(D-galactosamine)
LPS
mal lactoferrin. Solid red line; the death signal transduction induced by
osomal lactoferrin. LRF; unknown lactoferrin releasing factor.
N. Katunuma et al. / FEBS Letters 580 (2006) 3699–3705 3705the cytoplasm by D-galactosamine plus LPS treatment was
5000–6000 AFC nM/h, this activity is corresponding to the
activity by 106–107 M of lactoferrin (calculated by
Fig. 3(b)). This amount (concentration) is enough to activate
procaspase-3 in vitro. Suﬃcient amounts of procaspase-3 are
located in the normal liver cytoplasm, but caspase-3 was not
present in the normal cytoplasm. As a model experiment, the
caspase-3 activity (DEVD-AFC cleaving activity) in a normal
liver cytoplasm preparation was found to be strongly enhanced
by the addition of recombinant lactoferrin in vitro. We re-
ported in our previous papers that the caspase-3 activity in
the normal liver cytoplasm was enhanced by the addition of
digitonin extracts of lysosomes in vitro [5,6]. The activities of
other known caspases [6,8,11,13], which are the proteolytic sig-
nal transduction caspases, were not changed by the D-galactos-
amine treatment (data not shown). When a suitable death
signal was added, the corresponding activating protein was
translocated from the diﬀerent organelles into the cytoplasm,
resulting in increases in caspase-3 mediated apoptosis, in gen-
eral [1]. The releasing mechanism of lysosomal lactoferrin by
D-galactosamine treatment is not known. Quintero et al. re-
ported that prostaglandin E1 protection against apoptosis in-
duced by D-galactosamine is not related to the modulation
of intracellular free radical production in primary culture of
rat hepatocyte [19]. However, we have not any direct evidences
on the releasing mechanisms of lysosomal lactoferrin into cyto-
plasm by D-galactosamine induced hepatocyte apoptosis. Fuj-
ita et al. reported that lactoferrin stimulated the apoptosis of
azoxymethane-induced tumors and the elevation of active
forms of caspases-3 and 8. But little is known about the mech-
anisms at the molecular level. The problem of this report is
that the lactoferrin was administrated perorally with diet, it
is diﬃcult to consider that the 72-kDa lactoferrin is eﬀectively
absorbed from intestine [20]. The caspase-3 activity was dra-
matically elevated in the cytoplasm of D-galactosamine
induced apoptotic hepatocytes and administration of epi-
gallo-catechin gallate which was strong inhibitor for caspase-
3 activity suppressed the elevation of caspase-3 activity in the
cytoplasm and protected the hepatocyte apoptosis [11]. Our
proposed new apoptotic cascade mediated by lysosomal lacto-
ferrin is illustrated schematically in Fig. 5.
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